Skip to content
Breaking News

Breaking News

  • Home
  • World
  • Business
  • Health
  • Entertainment
  • Life Style
  • Sports
  • Toggle search form

Wegovy-maker Novo Nordisk raises outlook as sales of its weight-loss drug soar

Posted on August 10, 2023 By Admin No Comments on Wegovy-maker Novo Nordisk raises outlook as sales of its weight-loss drug soar


A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. 

Jim Vondruska | Reuters

Novo Nordisk, which makes the weight-loss drug Wegovy, raised its outlook for 2023 Thursday, as it reported soaring sales.

The Danish pharmaceutical company reported a 30% increase in sales, at constant exchange rates, for the first half of this year to 107.7 million Danish kroner ($15.9 million). Net profit increased 43%, coming in at 39.2 million kroner.

The company’s diabetes and obesity division performed particularly well, bolstered by interest in its blockbuster injection Wegovy.

“The [sales] growth is driven by increasing demand for our GLP-1-based diabetes and obesity treatments, and we are serving more patients than ever before,” Lars Fruergaard Jørgensen, president and CEO, said in a statement. “The performance in the first six months has enabled us to raise the outlook for the full year.”

For 2023, the company now anticipates sales growth of 27%-33% and operating profit growth of 31%-37%, at constant exchange rates.

Last week, late-stage trial data showed that Wegovy reduced the risk of major cardiovascular events such as heart attacks or strokes by 20%, compared with a placebo, sending shares higher.

The results of the closely watched “SELECT” trial, which exceeded expectations, were seen as a major boost for the company’s hopes of moving beyond Wegovy’s image as a “vanity drug.”

The active ingredient in Wegovy is semaglutide, an FDA-approved drug that works by imitating a naturally-occurring gut hormone that helps to regulate appetite.

Shares are up almost 1% in pre-market trading.

— Sam Meredith contributed to this report.



Source link

Health Tags:business news, Earnings, Health care industry, Novo Nordisk A/S

Post navigation

Previous Post: Amazon in talks to become anchor investor in Arm ahead of IPO  – Reuters News Agency
Next Post: Wells Fargo Reflect Card Review

More Related Articles

One Family’s Toxic Train Wreck Ordeal: Illness, Exile and Debt Health
Hims & Hers says it’s selling a GLP-1 weight loss drug for 85% less than Wegovy. Here’s the price. Health
Home remedies for dry skin – SUCH TV Health
Doctors question union over puberty blocker statement Health
Unprecedented outbreak of 'flesh-eating' bacteria sweeps Japan – SUCH TV Health
Judge Orders Timely Housing for Migrant Children Waiting at Border Health

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Abortion guidelines branded horrifying by grieving mum
  • Woman declared dead by coroner, moved to coffin, turns out to be alive
  • Shohei Ohtani reacts to death of Japanese baseball legend Shigeo Nagashima: ‘May your soul rest in peace’
  • Thames Water nationalisation ‘not the answer’ says minister after rescue bid fails
  • “Family Guy” creator Seth MacFarlane on his other love: Sinatra

Categories

  • Business
  • Entertainment
  • Health
  • Life Style
  • Sports
  • World

Copyright © 2025 Breaking News.

Powered by PressBook Blog WordPress theme